Joanna E. MacLean
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Joanna E. MacLean has a total of 288 co-authors. Here are the top co-authors by number of shared publications:
Dominic A. Fitzgerald
Discipline of Paediatrics & Child Health, Sydney Medical School, University of Sydney, Australia; Department of Respiratory Medicine, The Children's Hospital at Westmead, Sydney, NSW, Australia
5 shared publicationsEvelyn Constantin
Pediatric Sleep Medicine, Department of Pediatrics, Montreal Children's Hospital, Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada
5 shared publicationsGiampiero Bartolucci
5 shared publicationsKaren A. Waters
Sydney Medical School, University of Sydney, Sydney, NSW, Australia
5 shared publications- Maria Luisa Castro Codesal
Department of Pediatrics, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Canada
5 shared publications Marshall B. Jones
5 shared publications
Latest Publications
- Open Access
- 1 April 2026
- Published by European Respiratory Society (ERS) in European Respiratory Review
- Vol. 35 (180) , 250231
Implementation of long-term noninvasive positive airway pressure therapy in patients with COPD: a systematic review and meta-analysis of acceptance and adherence
Background: Long-term noninvasive positive airway pressure (PAP) therapy is an effective, albeit complex, intervention for obstructive sleep apnoea (OSA) and/or chronic hypercapnic respiratory failure (CHRF) in patients with chronic obstructive pulmonary disease (COPD). PAP uptake and use is often reported in studies designed for other purposes. Systematic review methods were used to summarise acceptance of and adherence with PAP therapy. Methods: A systematic search for studies that reported the proportion of patients that either declined or accepted PAP therapy and/or objective use of newly prescribed PAP therapy in patients with COPD was conducted according to a predefined protocol (PROSPERO CRD42021259262). Meta-analysis and meta-regression techniques were used to establish summary effect estimates and explore heterogeneity. Results: On average, PAP therapy was declined or discontinued by 14% (95% CI 10–19) of participants, often within 6 weeks of initiation among studies reporting repeated measures. The pooled median adherence was 6.3 h·day −1 (95% CI 5.9–6.6). While meta-regression found higher acceptance (p=0.03) and shorter use per day (pversus CHRF, this explained only some heterogeneity in the summary effect estimates. Summary of study-level variables associated with acceptance or adherence highlighted limitations in the available literature. Conclusions: An anticipated six out of seven patients with COPD newly prescribed PAP therapy will be successful using therapy; however, heterogeneity was substantial among studies, and only partly explained by indication for use. Prospective studies to explore barriers to use and detailed reporting of acceptance and adherence in studies on PAP therapy in patients with COPD are needed.
- 1 April 2026
- Published by European Respiratory Society (ERS) in European Respiratory Review
- Vol. 35 (180) , 250231
Open AccessImplementation of long-term noninvasive positive airway pressure therapy in patients with COPD: a systematic review and meta-analysis of acceptance and adherence
Background: Long-term noninvasive positive airway pressure (PAP) therapy is an effective, albeit complex, intervention for obstructive sleep apnoea (OSA) and/or chronic hypercapnic respiratory failure (CHRF) in patients with chronic obstructive pulmonary disease (COPD). PAP uptake and use is often reported in studies designed for other purposes. Systematic review methods were used to summarise acceptance of and adherence with PAP therapy. Methods: A systematic search for studies that reported the proportion of patients that either declined or accepted PAP therapy and/or objective use of newly prescribed PAP therapy in patients with COPD was conducted according to a predefined protocol (PROSPERO CRD42021259262). Meta-analysis and meta-regression techniques were used to establish summary effect estimates and explore heterogeneity. Results: On average, PAP therapy was declined or discontinued by 14% (95% CI 10–19) of participants, often within 6 weeks of initiation among studies reporting repeated measures. The pooled median adherence was 6.3 h·day −1 (95% CI 5.9–6.6). While meta-regression found higher acceptance (p=0.03) and shorter use per day (pversus CHRF, this explained only some heterogeneity in the summary effect estimates. Summary of study-level variables associated with acceptance or adherence highlighted limitations in the available literature. Conclusions: An anticipated six out of seven patients with COPD newly prescribed PAP therapy will be successful using therapy; however, heterogeneity was substantial among studies, and only partly explained by indication for use. Prospective studies to explore barriers to use and detailed reporting of acceptance and adherence in studies on PAP therapy in patients with COPD are needed.
- 24 March 2026
- Published by Taylor & Francis in Canadian Journal of Respiratory, Critical Care, and Sleep Medicine
- Vol. 10 (4) , 1-24
The Canadian Thoracic Society/Canadian Sleep Society Guideline on the diagnosis of obstructive sleep apnea in children
IntroductionObstructive sleep apnea (OSA) is a common condition affecting 1–5% of children.1 Multiple factors contribute to the risk of OSA in children with differences in the presentation by age a...
- 24 March 2026
- Published by Taylor & Francis in Canadian Journal of Respiratory, Critical Care, and Sleep Medicine
- Vol. 10 (4) , 1-24
The Canadian Thoracic Society/Canadian Sleep Society Guideline on the diagnosis of obstructive sleep apnea in children
IntroductionObstructive sleep apnea (OSA) is a common condition affecting 1–5% of children.1 Multiple factors contribute to the risk of OSA in children with differences in the presentation by age a...
- Open Access
- 5 February 2026
- Published by Elsevier in Paediatric Respiratory Reviews
Long-term non-invasive ventilation in children with central nervous system disorders: A systematic review and meta-analysis
- 5 February 2026
- Published by Elsevier in Paediatric Respiratory Reviews
Open AccessLong-term non-invasive ventilation in children with central nervous system disorders: A systematic review and meta-analysis
- 14 February 2025
- Published by Springer Nature in Sleep and Breathing
- Vol. 29 (1) , 105
Efficacy and outcomes of long-term non-invasive ventilation in children with Robin sequence
To describe the clinical characteristics and outcomes of children with Robin sequence (RS) using non-invasive ventilation (NIV), including continuous and bilevel positive airway pressure, and to compare these parameters to other children using this technology. This study is a sub-study of a multicenter retrospective 10-year cohort of children using long-term NIV. Children with RS were identified from medical chart review and matched by age, sex, and year of initiation to other children in the cohort. Clinical characteristics, NIV technology, and treatment effect and outcomes were extracted from the medical chart. From 622 children in the NIV cohort, 13 had RS and were matched to 39 comparators. Age at NIV initiation and comorbidities did not differ between groups. Use of gastrostomy/nasogastric tubes was higher in children with RS (OR 3.0, 95% CI 1.17-7.69). Neither the proportion of children with obstructive sleep apnea or obstructive apnea-hypopnea index ≥ 10 events/h differed between groups. Improvements in respiratory, oxygen, and carbon dioxide parameters between the diagnostic and treatment polysomnography were similar for children with RS and the comparison group. NIV start location was predominantly at home and for used during sleep in both groups. Children with RS used NIV for a median of 1.45 (IQR 1.85) years. The most common reason for stopping NIV in both groups was an improvement in the underlying condition. Children with RS have similar characteristics and outcomes to other children using NIV. A high proportion of children with RS cease NIV use because of improvements in the underlying primary condition leading to NIV.
- 14 February 2025
- Published by Springer Nature in Sleep and Breathing
- Vol. 29 (1) , 105
Efficacy and outcomes of long-term non-invasive ventilation in children with Robin sequence
To describe the clinical characteristics and outcomes of children with Robin sequence (RS) using non-invasive ventilation (NIV), including continuous and bilevel positive airway pressure, and to compare these parameters to other children using this technology. This study is a sub-study of a multicenter retrospective 10-year cohort of children using long-term NIV. Children with RS were identified from medical chart review and matched by age, sex, and year of initiation to other children in the cohort. Clinical characteristics, NIV technology, and treatment effect and outcomes were extracted from the medical chart. From 622 children in the NIV cohort, 13 had RS and were matched to 39 comparators. Age at NIV initiation and comorbidities did not differ between groups. Use of gastrostomy/nasogastric tubes was higher in children with RS (OR 3.0, 95% CI 1.17-7.69). Neither the proportion of children with obstructive sleep apnea or obstructive apnea-hypopnea index ≥ 10 events/h differed between groups. Improvements in respiratory, oxygen, and carbon dioxide parameters between the diagnostic and treatment polysomnography were similar for children with RS and the comparison group. NIV start location was predominantly at home and for used during sleep in both groups. Children with RS used NIV for a median of 1.45 (IQR 1.85) years. The most common reason for stopping NIV in both groups was an improvement in the underlying condition. Children with RS have similar characteristics and outcomes to other children using NIV. A high proportion of children with RS cease NIV use because of improvements in the underlying primary condition leading to NIV.
- Open Access
- 28 November 2024
- Published by Frontiers Media SA in Frontiers in Sleep
- Vol. 3, 1459349
The experience of children using long-term non-invasive ventilation: a qualitative study
Objectives: To identify factors to optimize long-term non-invasive ventilation (LT-NIV) use by exploring the experience of children using LT-NIV and their parents.Study design and methods: A qualitative framework analysis method was used. Children aged 8–12 years who used LT-NIV for at least 3-months and their parents/guardians were approached to participate. Thematic analysis of data derived from focus group interviews, conducted separately for children and parents, was performed. Findings were coded and grouped into identified themes.Results: Data analysis identified four themes: (1) “The double-edged sword,” which identified benefits and challenges of LT-NIV use; (2) “Feeling different,” where children and parents described fears, frustrations, and concerns including emotional and social implications, and physical changes; (3) “It's not just about the mask,” highlighted the influence of equipment issues, including the mask interface, headgear, tubing and humidity, and their impact on tolerance and use of LT-NIV; and (4) “Through the eyes of experience—children and parents as experts for change,” which captured ideas for the functional and aesthetic improvement of the equipment including the need for pediatric specific technology.Conclusions: LT-NIV use has two sides; it helps to improve lives though requires an investment of time and commitment to ensure success. Investing in pediatric-specific equipment needs to be a priority as do alliances between healthcare providers, children who use LT-NIV, and their families. Future technology development and studies of adherence need to consider the experiences of children and their families to reduce the challenges and support optimal use of LT-NIV.
- 28 November 2024
- Published by Frontiers Media SA in Frontiers in Sleep
- Vol. 3, 1459349
Open AccessThe experience of children using long-term non-invasive ventilation: a qualitative study
Objectives: To identify factors to optimize long-term non-invasive ventilation (LT-NIV) use by exploring the experience of children using LT-NIV and their parents.Study design and methods: A qualitative framework analysis method was used. Children aged 8–12 years who used LT-NIV for at least 3-months and their parents/guardians were approached to participate. Thematic analysis of data derived from focus group interviews, conducted separately for children and parents, was performed. Findings were coded and grouped into identified themes.Results: Data analysis identified four themes: (1) “The double-edged sword,” which identified benefits and challenges of LT-NIV use; (2) “Feeling different,” where children and parents described fears, frustrations, and concerns including emotional and social implications, and physical changes; (3) “It's not just about the mask,” highlighted the influence of equipment issues, including the mask interface, headgear, tubing and humidity, and their impact on tolerance and use of LT-NIV; and (4) “Through the eyes of experience—children and parents as experts for change,” which captured ideas for the functional and aesthetic improvement of the equipment including the need for pediatric specific technology.Conclusions: LT-NIV use has two sides; it helps to improve lives though requires an investment of time and commitment to ensure success. Investing in pediatric-specific equipment needs to be a priority as do alliances between healthcare providers, children who use LT-NIV, and their families. Future technology development and studies of adherence need to consider the experiences of children and their families to reduce the challenges and support optimal use of LT-NIV.
- 2 September 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Sensors Journal
- Vol. 24 (20) , 32283-32290
Characterization of Wearable Respiratory Sensors for Breathing Parameter Measurements
Controlling and treating respiratory diseases requires monitoring of the respiratory system. Conventional monitoring systems lack portability, which makes continuous monitoring difficult. The accuracy and reliability of portable monitoring technologies, such as wearable sensors, have rarely been characterized. This study characterized measurements of a commercial respiratory sensor in measuring tidal volume, inhalation time, and respiratory rate based on the measurement of abdominal/thoracic movements. The respiratory sensor was evaluated when placed at the thoracic spine (at the T6 and T12 vertebrae) and the abdomen (at the L3 vertebra) to find a suitable sensor location. Each test also included three breathing patterns (shallow normal, and deep) to calibrate the respiratory sensor against a flow sensor. The results showed that the respiratory sensor placement on either thorax location offered more accurate tidal volume estimation. Additionally, implementing an individualized calibration formula outperformed using a universal formula for all participants. The study involved two visits for each participant to assess how accurately the calibration formulation for estimating tidal volume, determined during the first visit, performed during the second visit. The maximum mean relative error of tidal volume increased from 19% at the first visit to 35% at the second visit. The mean relative error of respiration rate and inhalation time remained below 13% and 26%, respectively, across all breathing patterns studied. This highlights the necessity of recalibration before each measurement to obtain more accurate tidal volume estimations. These observations may explain the extent of reliability of the wearable respiratory sensor for at-home daily monitoring.
- 2 September 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Sensors Journal
- Vol. 24 (20) , 32283-32290
Characterization of Wearable Respiratory Sensors for Breathing Parameter Measurements
Controlling and treating respiratory diseases requires monitoring of the respiratory system. Conventional monitoring systems lack portability, which makes continuous monitoring difficult. The accuracy and reliability of portable monitoring technologies, such as wearable sensors, have rarely been characterized. This study characterized measurements of a commercial respiratory sensor in measuring tidal volume, inhalation time, and respiratory rate based on the measurement of abdominal/thoracic movements. The respiratory sensor was evaluated when placed at the thoracic spine (at the T6 and T12 vertebrae) and the abdomen (at the L3 vertebra) to find a suitable sensor location. Each test also included three breathing patterns (shallow normal, and deep) to calibrate the respiratory sensor against a flow sensor. The results showed that the respiratory sensor placement on either thorax location offered more accurate tidal volume estimation. Additionally, implementing an individualized calibration formula outperformed using a universal formula for all participants. The study involved two visits for each participant to assess how accurately the calibration formulation for estimating tidal volume, determined during the first visit, performed during the second visit. The maximum mean relative error of tidal volume increased from 19% at the first visit to 35% at the second visit. The mean relative error of respiration rate and inhalation time remained below 13% and 26%, respectively, across all breathing patterns studied. This highlights the necessity of recalibration before each measurement to obtain more accurate tidal volume estimations. These observations may explain the extent of reliability of the wearable respiratory sensor for at-home daily monitoring.
- Open Access
- 1 April 2024
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 21 (4) , 545-547
Neighborhood Disadvantage Impacts Symptoms and Quality of Life in Children with Habitual Snoring
- 1 April 2024
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 21 (4) , 545-547
Open AccessNeighborhood Disadvantage Impacts Symptoms and Quality of Life in Children with Habitual Snoring
- Open Access
- 3 July 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (7) , e0287887
Acceptance of and adherence with long-term positive airway pressure treatment in adults with chronic obstructive pulmonary disease: A systematic review protocol
Background: Long-term noninvasive positive airway pressure (PAP) treatment is effective treatment for sleep-related breathing disorders and chronic hypercarbic respiratory failure secondary to chronic obstructive pulmonary disease (COPD). PAP treatment may be delivered as continuous positive airway pressure or noninvasive ventilation. Success in initiating PAP treatment and barriers to its use in adult patients with COPD are largely unknown. This systematic review aims to identify the acceptance of and adherence to PAP treatment prescribed for long-term use in adult patients with COPD and to summarize variables associated with these measures. Methods: Seven online electronic databases will be searched by an experienced medical librarian to identify records containing the concepts “obstructive airways disease” and “noninvasive positive airway pressure” and “acceptance” or “adherence”. Randomized and non-randomized studies of interventions will be included. Citation lists from relevant articles will be reviewed, and experts will be contacted regarding unpublished studies. Abstracts from key conferences between 2018–2023 and Google Scholar search results will be reviewed for inclusion. Titles, abstracts and full texts will be reviewed independently for inclusion by two reviewers. Data extraction will be completed by one author using a pre-established form and primary outcomes confirmed by a second author. Methodological quality will be evaluated. If sufficient data are available for meta-analysis, a pooled summary statistic for the primary outcome will be calculated using a random-effects generic inverse-variance meta-analysis, weighted proportion or weighted medians-based approach. Subgroup analysis will explore clinically meaningful sources of heterogeneity. Variables that are associated with acceptance and adherence will be described. Discussion: Long-term PAP treatment is a complex intervention prescribed to patients with COPD for several indications. Synthesis of the evidence on success with PAP treatment and variables associated with acceptance or adherence will inform program and policy development for supporting patients with COPD who are prescribed this therapy. Trial registration: Systematic review registration: This protocol was registered with the International Prospective Register of Systematic Reviews (PROSPERO) on July 13, 2021 (registration number CRD42021259262), with revisions submitted on April 17, 2023.
- 3 July 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (7) , e0287887
Open AccessAcceptance of and adherence with long-term positive airway pressure treatment in adults with chronic obstructive pulmonary disease: A systematic review protocol
Background: Long-term noninvasive positive airway pressure (PAP) treatment is effective treatment for sleep-related breathing disorders and chronic hypercarbic respiratory failure secondary to chronic obstructive pulmonary disease (COPD). PAP treatment may be delivered as continuous positive airway pressure or noninvasive ventilation. Success in initiating PAP treatment and barriers to its use in adult patients with COPD are largely unknown. This systematic review aims to identify the acceptance of and adherence to PAP treatment prescribed for long-term use in adult patients with COPD and to summarize variables associated with these measures. Methods: Seven online electronic databases will be searched by an experienced medical librarian to identify records containing the concepts “obstructive airways disease” and “noninvasive positive airway pressure” and “acceptance” or “adherence”. Randomized and non-randomized studies of interventions will be included. Citation lists from relevant articles will be reviewed, and experts will be contacted regarding unpublished studies. Abstracts from key conferences between 2018–2023 and Google Scholar search results will be reviewed for inclusion. Titles, abstracts and full texts will be reviewed independently for inclusion by two reviewers. Data extraction will be completed by one author using a pre-established form and primary outcomes confirmed by a second author. Methodological quality will be evaluated. If sufficient data are available for meta-analysis, a pooled summary statistic for the primary outcome will be calculated using a random-effects generic inverse-variance meta-analysis, weighted proportion or weighted medians-based approach. Subgroup analysis will explore clinically meaningful sources of heterogeneity. Variables that are associated with acceptance and adherence will be described. Discussion: Long-term PAP treatment is a complex intervention prescribed to patients with COPD for several indications. Synthesis of the evidence on success with PAP treatment and variables associated with acceptance or adherence will inform program and policy development for supporting patients with COPD who are prescribed this therapy. Trial registration: Systematic review registration: This protocol was registered with the International Prospective Register of Systematic Reviews (PROSPERO) on July 13, 2021 (registration number CRD42021259262), with revisions submitted on April 17, 2023.
- Open Access
- 19 May 2023
- Published by Frontiers Media SA in Frontiers in Sleep
- Vol. 2
Comparison of non-invasive ventilation use and outcomes in children with Down syndrome and other children using this technology
Rationale: Children with Down syndrome (DS) make up a substantial portion of long-term non-invasive ventilation (LT-NIV) users though it is unclear if their unique features alter LT-NIV efficacy or use. The aim of this study is to compare the use and outcomes of LT-NIV for children with DS and a matched comparison (MCG).Methods: This is a sub-study of a 10-year retrospective review of children initiated on LT-NIV in Alberta, Canada (N = 622). Children with DS (n = 106) were matched in a 1:2 ratio with other children using LT-NIV based on age and therapy start date. Data was collected from medical and sleep laboratory records.Results: Upper airway disease was the most common indication for LT-NIV in both groups, though was higher in children with DS (DS: 90% vs. MCG: 50%, OR 8.64 [95% CI 4.38–17.04]). Sleep and respiratory parameters, at the baseline diagnostic sleep study and the change from baseline to treatment study, did not differ between groups. Nasal masks were the predominant mask type in both children with DS (55%) and the MCG (66%) with more children with DS, compared to the MCG, using full face masks (DS: 45 vs. MCG: 33%, p < 0.05). Continuous positive airway pressure was used more often in children with DS (93.3% vs. 69.2%, p < 0.001) while bilevel-positive airway pressure was more common in the MCG (DS: 6.7% vs. MCG 30.8%, p < 0.001). Children with DS were followed longer than children in the MCG (DS: 2.4 [IQR 2.8] vs. MCG: 1.8 [IQR 2.7] years, p < 0.05). Adherence was lower in children with DS at both 6–12 month follow-up and most recent visit with a similar decrease in adherence in both groups over the follow-up period (0.0 [IQR 1.4] vs. −0.3 [IQR 2.0]. Despite this, 66% and 49% of children with DS used LT-NIV for more than 4 h/night at the 6–12 month and most current visit, respectively. Discontinuation of LT-NIV and mortality did not differ between groups.Conclusion: LT-NIV is a common and efficacious treatment in children with DS used predominantly for upper airway obstruction. While adherence is lower, the majority of children with DS are successful at using LT-NIV.
- 19 May 2023
- Published by Frontiers Media SA in Frontiers in Sleep
- Vol. 2
Open AccessComparison of non-invasive ventilation use and outcomes in children with Down syndrome and other children using this technology
Rationale: Children with Down syndrome (DS) make up a substantial portion of long-term non-invasive ventilation (LT-NIV) users though it is unclear if their unique features alter LT-NIV efficacy or use. The aim of this study is to compare the use and outcomes of LT-NIV for children with DS and a matched comparison (MCG).Methods: This is a sub-study of a 10-year retrospective review of children initiated on LT-NIV in Alberta, Canada (N = 622). Children with DS (n = 106) were matched in a 1:2 ratio with other children using LT-NIV based on age and therapy start date. Data was collected from medical and sleep laboratory records.Results: Upper airway disease was the most common indication for LT-NIV in both groups, though was higher in children with DS (DS: 90% vs. MCG: 50%, OR 8.64 [95% CI 4.38–17.04]). Sleep and respiratory parameters, at the baseline diagnostic sleep study and the change from baseline to treatment study, did not differ between groups. Nasal masks were the predominant mask type in both children with DS (55%) and the MCG (66%) with more children with DS, compared to the MCG, using full face masks (DS: 45 vs. MCG: 33%, p < 0.05). Continuous positive airway pressure was used more often in children with DS (93.3% vs. 69.2%, p < 0.001) while bilevel-positive airway pressure was more common in the MCG (DS: 6.7% vs. MCG 30.8%, p < 0.001). Children with DS were followed longer than children in the MCG (DS: 2.4 [IQR 2.8] vs. MCG: 1.8 [IQR 2.7] years, p < 0.05). Adherence was lower in children with DS at both 6–12 month follow-up and most recent visit with a similar decrease in adherence in both groups over the follow-up period (0.0 [IQR 1.4] vs. −0.3 [IQR 2.0]. Despite this, 66% and 49% of children with DS used LT-NIV for more than 4 h/night at the 6–12 month and most current visit, respectively. Discontinuation of LT-NIV and mortality did not differ between groups.Conclusion: LT-NIV is a common and efficacious treatment in children with DS used predominantly for upper airway obstruction. While adherence is lower, the majority of children with DS are successful at using LT-NIV.